NewAmsterdam Pharma Company NV (NAMSW) Q2 2024 Earnings

9MayConfirmed
Q2 2024
-1.06
-0.91
-0.77
-0.62

Details

Expected EPS
-0.617915
Actual EPS
-1.06
Surprise EPS
-0.44
Surprise Percent
+71.54%

Description

NewAmsterdam Pharma Company NV (NAMSW) has reported earnings of -1.06 per share for Q2 2024.

0 Comments

Share your thoughts